Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -5.08% | +3.70% |
2020 | Mark Corrigan Departs as CEO from Correvio Pharma Corp | CI |
2020 | Justin Renz, CFO Departs from Correvio Pharma Corp | CI |
Sales 2018 | 28.67M 39.21M 2.39B | Sales 2019 | 32.63M 44.63M 2.72B | Capitalization | 27.28M 37.31M 2.28B |
---|---|---|---|---|---|
Net income 2018 | -16M -21.88M -1.33B | Net income 2019 | -35M -47.86M -2.92B | EV / Sales 2018 | 5.13 x |
Net Debt 2018 | 25.92M 35.45M 2.16B | Net Debt 2019 | 33.9M 46.37M 2.83B | EV / Sales 2019 | 1.87 x |
P/E ratio 2018 |
-7.1
x | P/E ratio 2019 |
-0.68
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 86.23% |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Ramkumar
BRD | Director/Board Member | - | - |
Andreas Stickler
BRD | Director/Board Member | 53 | - |
Robert Ford
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+3.70% | 27.65M | |
+8.05% | 72.03B | |
-11.95% | 5.14B | |
+51.87% | 4.6B | |
+3.92% | 3.96B | |
-14.26% | 2.5B | |
+20.42% | 2.43B | |
-23.94% | 2.32B | |
+20.02% | 2.18B | |
+3.66% | 1.72B |
- Stock Market
- Equities
- CORV Stock